Trial NCT02565511

View at ClinicalTrials.gov 
Org. Study IDs: CAPI015A2201J
Secondary IDs: 1UF1AG046150-01 2015-002715-15

Last trial update was posted on 2021-07-08

MeSH Interventions

Umibecestat

MeSH Conditions

Alzheimer Disease

Other Conditions

Alzheimers Disease

Stopping Reasons

N/A

Limitations And Caveats

The study was terminated due to unexpected changes in cognitive function, brain volume loss, and body weight loss. Cohort II (CNP520) treatment was stopped and evaluated through an off-treatment follow-up period. After the decision to terminate Cohort II of the study (CNP520), treatment with CAD106 (Cohort I) was also terminated

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID